HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Salon City to launch Internet programming

This article was originally published in The Rose Sheet

Executive Summary

Publisher of Salon City magazine says it is finalizing plans for launch of its new Internet programming vehicle, Salon City Network, which will offer "entertaining and educational articles and photos in the areas of beauty, fashion and lifestyle," video content aggregated from across the Web, and original content produced by entertainment production company Matrixx. "These videos can also feature deep product and brand integration and information from advertisers," Matrixx Executive Producer Van Vandegrift notes in July 26 release. SCI President and CEO Steven Casciola adds: "The network will offer brands more immediate opportunities to connect with consumers via targeted advertising and compelling special offers." The network will follow an end-of-the-summer unveiling of Salon City's revamped Web site. Beauty TV recently announced it is partnering with Joost to offer beauty-focused, on-demand television via the Internet (1"The Rose Sheet" July 16, 2007, p. 3)...

You may also be interested in...

Beauty TV Network To Grow Its Web Presence Through Partnership With Joost

Beauty TV - "the world's only 24/7 beauty television network" - will enjoy expanded distribution worldwide after partnering with Joost, touted as "a new way of watching TV on the Internet.

Formycon Chief Sees COVID-19 Boosting Biosimilars

Formycon’s CEO has offered the latest indication that the coronavirus outbreak could provide a tailwind for biosimilars, as the firm gave an update on its biosimilars pipeline – including ranibizumab, ustekinumab, aflibercept and an undisclosed molecule, as well as other unrevealed projects – and how it has been affected by the pandemic.

PDUFA Renewal Negotiations: What Does Industry Want Now?

With the formal, virtual kick-off meeting set for 23 July, US FDA and sponsors are looking at a transformed landscape as they discuss what the next five years of user fees will look like.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts